Proliferative Diabetic Retinopathy (PDR) Completed Phase 1 / 2 Trials for Ranibizumab (DB01270)

Back to Proliferative Diabetic Retinopathy (PDR)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

IndicationStatusPhase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00606138
Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field ImagingTreatment